Latest
Thursday, October 21, 2021
Biogen CEO: 'Major Bottleneck' Still Limits Alzheimer's Drug
A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market.
No comments:
Post a Comment
Please Don't Send any Spam Link in Comments
‹
›
Home
View web version
https://draft.blogger.com/u/1/blog/themes/edit/7199067120201458512
No comments:
Post a Comment
Please Don't Send any Spam Link in Comments